Concurrent Nivolumab-Induced Gastritis and Cholangitis Accompanied by Biliary Tract Hemorrhage in a Patient With Stage IV Lung Adenocarcinoma

Immune checkpoint inhibitors, including nivolumab, can result in immune-related adverse events (irAEs) that may affect multiple organ systems. Among irAEs, both gastritis and cholangitis are uncommon. We present the case of a 65-year-old man who received nivolumab for lung adenocarcinoma presented w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsukaguchi, Akihiro, Yamaguchi, Norihiko, Ogawa, Hiroyuki, Ikeda, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620473/
https://www.ncbi.nlm.nih.gov/pubmed/37927718
http://dx.doi.org/10.7759/cureus.46392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620473/
https://www.ncbi.nlm.nih.gov/pubmed/37927718
http://dx.doi.org/10.7759/cureus.46392

Ejemplares similares